Aktienanalyse zu Ashland Inc. (ASH)ASHAshland Inc.

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone. It operates in the Basic Materials sector (WHOLESALE-CHEMICALS & ALLIED PRODUCTS industry).

Ashland Inc is a good buy right now, trading at $70.57, with a forward P/E of 15.748 indicating reasonable valuation compared to its growth prospects. The stock has shown a 1-year change of +45.96%, reflecting strong recovery and growth in sales, which increased by 7% to $497 million in Q3. However, the main risk is the negative net income margin of -3.63% in Q1 2026, which highlights ongoing profitability challenges.

11 analysts cover ASH: 8 rate it Buy, 3 Hold and 0 Sell. The average price target is 66.67.